Initiating Development of Psychedelic Prodrugs with Long-established Compounding Pharmacy
VANCOUVER, BC / ACCESSWIRE / May 1, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6)(WKN:A3CSSU) (the "Company" or "Core One") is pleased to announce that its...
Cube Psytech Signs Letter of Intent to Acquire Translational Life Sciences and Announces Private Placement
VANCOUVER, BC / ACCESSWIRE / February 10, 2023 / Cube Psytech Holdings Inc. (the "Company" or "CUBE"), a biopharmaceutical and biotechnology company focused on the...